VXT-14326-14408
3 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 937 / CA
- Registered
- 2021-10-10
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2021-10-10
Registered in v-safe
-
2021-10-10
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessFree text: axillary lymph node tendernessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-11
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tirednessFree text: Axillary lynph node tenderness and pain. Mammillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-11-14
- 2022-01-07
- 2022-04-08
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | No |
| 2 | 2021-01-12 | Pfizer-BioNTech | No |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): axillary lymph node tenderness
Systemic reaction (other): Axillary lynph node tenderness and pain. Mammillary lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release